Karuna Therapeutics onboards William P. Kane as CCO
Karuna Therapeutics, Inc. , a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, recently announces the appointment of Will Kane as chief commercial officer (CCO), effective February 6, 2023. “The addition of Will to our executive team represents an important step as we execute on […]